Vaishali Pharma share news and announcements
NSE: VAISHALIPharmaceuticals & BiotechnologySmall Cap
Last close ₹6.87down ₹0.36 (4.98%)
Share price at the NSE close on 23 Oct 2026. Previous close ₹7.23.
52-week range of traded prices to 23 Oct 2026
₹4.75Low, 30 Mar 2026₹11.15High, 28 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹90 Cr2,938th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- 20.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- 1.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it, the company's own balance sheet from before it began consolidating; the two agree where both are first on record.
- 6.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 4.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.27
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 2,61,33858.6% delivered
Vaishali Pharma routine notices
108 filed, newest first. Page 2 of 3.
May 2023
24 May · Routine
Apr 2023
Mar 2023
Feb 2023
10 Feb · Routine
Jan 2023
Dec 2022
30 Dec · Routine
24 Dec · Routine
13 Dec · Routine
Nov 2022
4 Nov · Routine
Sep 2022
29 Sep · Routine
9 Sep · Routine
3 Sep · Routine
Jul 2022
26 Jul · Routine
19 Jul · Routine
Jun 2022
30 Jun · Routine
May 2022
31 May · Routine
24 May · Routine
Mar 2022
31 Mar · Routine
Jan 2022
22 Jan · Routine
15 Jan · Routine
Dec 2021
Nov 2021
12 Nov · Routine
3 Nov · Routine
Oct 2021
Sep 2021
8 Sep · Routine
6 Sep · Routine
Jul 2021
25 Jul · Routine
18 Jul · Routine
14 Jul · Routine
12 Jul · Routine
Jun 2021
May 2021
15 May · Routine
7 May · Routine
Apr 2021
Mar 2021
Jan 2021
20 Jan · Routine
13 Jan · Routine
Dec 2020
Oct 2020
13 Oct · Routine
7 Oct · Routine
Sep 2020
8 Sep · Routine
4 Sep · Routine